Bolamperti Simona, Villa Isabella, di Filippo Luigi
Endocrine and Osteometabolic Lab, Institute of Endocrine and Metabolic Sciences, IRCCS San Raffaele Hospital, Via Olgettina 58, Milan, 20132, Italy.
Institute of Endocrine and Metabolic Sciences, Università Vita-Salute San Raffaele, IRCCS Ospedale San Raffaele, Milan, Italy.
Pituitary. 2024 Dec;27(6):745-751. doi: 10.1007/s11102-024-01464-2. Epub 2024 Oct 30.
Growth hormone is fundamental for growth during childhood and for maintaining bone mass and homeostasis in the adults. GH deficiency causes decreased bone growth and osteopenia, whereas GH excess causes increased bone fragility and decreased bone quality. In the past, it was common knowledge that GH effects on the skeletal system were due to the production of IGF1 from the liver, which has a huge bone anabolic effect per se. However, with the progress of basic research techniques new light has been shed on the mechanisms underlying GH effect in bone, and it is now clear that GH has effects that go beyond the downstream activation of liver IGFs. Therefore, the purpose of this review is to summarize the milestones in basic research that led to the discovery of GH local activity on bone.
生长激素对于儿童期的生长以及维持成年人的骨量和体内平衡至关重要。生长激素缺乏会导致骨生长减少和骨质减少,而生长激素过量则会导致骨脆性增加和骨质量下降。过去,人们普遍认为生长激素对骨骼系统的作用是由于肝脏产生胰岛素样生长因子1(IGF1),其本身就具有巨大的骨合成代谢作用。然而,随着基础研究技术的进步,关于生长激素对骨骼作用的潜在机制有了新的认识,现在很清楚生长激素的作用不仅仅局限于肝脏IGF的下游激活。因此,本综述的目的是总结基础研究中的一些重要进展,这些进展促成了生长激素对骨骼局部作用的发现。